Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users

被引:102
作者
Palamar, Joseph J. [1 ,2 ]
Salomone, Alberto [3 ]
Vincent, Marco [3 ,4 ]
Cleland, Charles M. [2 ,5 ]
机构
[1] NYU, Langone Med Ctr, Dept Populat Hlth, New York, NY USA
[2] NYU, Coll Nursing, Ctr Drug Use & HIV Res, New York, NY USA
[3] Ctr Reg Antidoping & Tossicol A Bertinaria, Turin, Italy
[4] Univ Turin, Dipartimento Chim, Turin, Italy
[5] NYU, Coll Nursing, New York, NY USA
基金
美国国家卫生研究院;
关键词
Ecstasy; Novel psychoactive substances; Nightclubs; Dance festivals; Synthetic cathinones; NATIONALLY REPRESENTATIVE SAMPLE; AMERICAN ASSOCIATION; ECSTASY TABLETS; DRUG-USE; PREVALENCE; MDMA; MEPHEDRONE; ABUSE; KID;
D O I
10.1016/j.drugalcdep.2016.02.001
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Ecstasy (MDMA) in the US is commonly adulterated with other drugs, but research has not focused on purity of ecstasy since the phenomenon of "Molly" (ecstasy marketed as pure MDMA) arose in the US. Methods: We piloted a rapid electronic survey in 2015 to assess use of novel psychoactive substances (NPS) and other drugs among 679 nightclub/festival-attending young adults (age 18-25) in New York City. A quarter (26.1%) of the sample provided a hair sample to be analyzed for the presence of select synthetic cathinones ("bath salts") and some other NPS. Samples were analyzed using fully validated UHPLC-MS/MS methods. To examine consistency of self-report, analyses focused on the 48 participants with an analyzable hair sample who reported lifetime ecstasy/MDMA/Molly use. Results: Half (50.0%) of the hair samples contained MDMA, 47.9% contained butylone, and 10.4% contained methylone. Of those who reported no lifetime use of "bath salts", stimulant NPS, or unknown pills or powders, about four out of ten (41.2%) tested positive for butylone, methylone, alpha-PVP, 5/6-APB, or 4 FA. Racial minorities were more likely to test positive for butylone or test positive for NPS after reporting no lifetime use. Frequent nightclub/festival attendance was the strongest predictor of testing positive for MDMA, butylone, or methylone. Discussion: Results suggest that many ecstasy-using nightclub/festival attendees may be unintentionally using "bath salts" or other NPS. Prevention and harm reduction education is needed for this population and "drug checking" (e.g., pill testing) may be beneficial for those rejecting abstinence. (c) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:200 / 205
页数:6
相关论文
共 40 条
[1]  
American Association of Poison Control Centers, 2015, BATH SALTS
[2]  
[Anonymous], 2014, RESULTS 2013 NATL SU
[3]  
[Anonymous], 2014, RES 2013 NAT SURV DR
[4]   Chemical analysis of ecstasy pills [J].
Baggott, M ;
Heifets, B ;
Jones, RT ;
Mendelson, J ;
Sferios, E ;
Zehnder, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (17) :2190-2190
[5]   2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report [J].
Bronstein, Alvin C. ;
Spyker, Daniel A. ;
Cantilena, Louis R., Jr. ;
Green, Jody L. ;
Rumack, Barry H. ;
Giffin, Sandra L. .
CLINICAL TOXICOLOGY, 2010, 48 (10) :979-1178
[6]   Emerging psychoactive substance use among regular ecstasy users in Australia [J].
Bruno, Raimondo ;
Matthews, Allison J. ;
Dunn, Matthew ;
Alati, Rosa ;
Mcllwraith, Fairlie ;
Hickey, Sophie ;
Burns, Lucy ;
Sindicich, Natasha .
DRUG AND ALCOHOL DEPENDENCE, 2012, 124 (1-2) :19-25
[7]   Instability of the ecstasy market and a new kid on the block: mephedrone [J].
Brunt, Tibor M. ;
Poortman, Anneke ;
Niesink, Raymond J. M. ;
van den Brink, Wim .
JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (11) :1543-1547
[8]   A web-based survey on mephedrone [J].
Carhart-Harris, R. L. ;
King, L. A. ;
Nutt, D. J. .
DRUG AND ALCOHOL DEPENDENCE, 2011, 118 (01) :19-22
[9]   Presence and composition of cathinone derivatives in drug samples taken from a Drug Test Service in Spain (2010-2012) [J].
Caudevilla-Galligo, Fernando ;
Ventura, Mireia ;
Indave Ruiz, Blanca Iciar ;
Fornis, Ivan .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (04) :341-344
[10]  
Cooper GA., 2015, HAIR ANAL CLIN FOREN, V1st, P1